Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Glaucoma affects more than 70 million people around the world, making it the leading cause of irreversible blindness. Primary care physicians can play an important role in detecting…
Juliann Reiland, MD, Surgeon, Avera Medical Group, discusses her goal to treat breast cancer while maintaining the look of the breast after surgery. Using intraoperative radiation, Dr. Reiland is…
Bobby Grajewski, MBA, President, Edison Nation Medical, introduces a new collaboration between the Carolinas Healthcare System and Edison Nation to create Edison Nation Medical, a healthcare incubator and…
Szilard Voros, MD, FACC, FSCCT, FAHA, Founder & CEO, Global Genomics Group (G3), explains his company’s goals to fill the two main gaps in treating cardiovascular disease: 1)…
Juliann Reiland, MD, Surgeon, Avera Medical Group, explains that breast conservation lumpectomy combined with a 6 week program of radiation that sterilizes the breast is the most effective…
Meike Uhler, MD, Obstetrics and Gynecology, Fertility Centers of Illinois, delves into endometriosis, a condition in which endometrium is found outside of the uterus. The 3 most common…
Type 1 diabetes is a life-long condition, usually requiring patients to inject themselves with insulin every day for the rest of their life. Type 2 diabetes can also…
Richard Tirendi, CEO & Co-founder, VisionQuest 20/20, assesses the shortcomings of traditional eye exams. He introduces EyeSpy 20/20, a proprietary vision screening software, that gamifies the vision screening process.…
Arlen Meyers, MD, MBA, President and CEO, Society of Physician Entrepreneurs, discusses the benefits of an MBA for physicians. He explains each of the vital 4 C’s offered by…
Time is critical after a patient experiences a stroke. If doctors can administer a clot dissolving drug to an eligible patient within 60 minutes after arriving at the…
